首页 > 专栏 > The Lancet Respiratory Medicine The Lancet Respiratory Medicine 共 99 条资讯 [Articles] Long-term safety and efficacy of twice-yearly depemokimab in type 2 asthma with an eosinophilic phenotype: 2-year integrated analysis of the phase 3a SWIFT-1 and SWIFT-2 studies and AGILE open-label extension 2026-06-28 11:50:22 [Comment] Twice-yearly depemokimab: beyond dosing convenience 2026-06-28 11:50:22 [Comment] Corticosteroid reduction and the endpoint challenge in sarcoidosis: striving for the lowest dose of uncertainty 2026-06-28 11:50:22 [Articles] Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 2026-06-28 11:50:22 [Personal View] Interstitial lung diseases in a changing climate: emerging risks and opportunities to improve care 2026-06-28 11:50:22 [Comment] When a vulnerable lung meets a changing climate 2026-06-28 11:50:22 [News] South Africa shifts away from salbutamol-only asthma relief 2026-06-28 11:50:22 [Articles] Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, internation 2026-06-28 11:50:22 [Comment] Amivantamab, lazertinib, and bevacizumab: a chemotherapy-free option for patients with advanced EGFR-mutant NSCLC with acquired resistance to a third-generation EGFR TKI 2026-06-28 11:50:22 [Editorial] Preparedness for conflict in medical facilities 2026-06-28 11:50:22 [News] European Respiratory Society International Congress 2026 2026-06-28 11:50:22 [Spotlight] Medical oxygen supply in Zambia: beyond COVID-19 2026-06-28 11:50:22 [Articles] Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis 2026-06-28 11:50:22 [Comment] Tuberculosis preventive treatment in high-burden settings: inequality in benefit, evidence, and potential harms 2026-06-28 11:50:22 [Comment] Understanding US state-level heterogeneity in chronic respiratory disease burden 2026-06-28 11:50:22 [Articles] State-level burden of chronic respiratory diseases in the USA, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 2026-06-28 11:50:22 [News] AI data centres could worsen US air pollution 2026-06-28 11:50:22 [Corrections] Correction to Lancet Respir Med 2026; published online Aug 25. https://doi.org/10.1016/S2213-2600(26)00192-X 2026-06-28 11:50:22 [Articles] Risk factors for hospital admission and mortality in patients with influenza virus infection: a systematic review and meta-analysis 2026-06-28 11:50:22 [Articles] Global hospital admission and case fatality risks among patients with influenza virus infection: a systematic review and meta-analysis 2026-06-28 11:50:22 123…5下一页 » 相关分类 The Lancet Respiratory Medicine The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心